Supreme Court Passes on Reviewing ERISA Action Against Anthem, Express Scripts over Drug Prices
- July 01, 2022
The Supreme Court declined June 27 to review a Second Circuit decision that affirmed the dismissal of a proposed class action alleging Anthem, Inc. and Express Scripts, Inc. breached their fiduciary duties under the Employee Retirement Income Security Act (ERISA) by entering into an agreement that resulted in health plans paying higher prices for prescription drugs.
ARTICLE TAGS
You must be logged in to access this content.